Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Anavex Lf SC (AVXL)

Anavex Lf SC (AVXL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,418,749
  • Shares Outstanding, K 75,707
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,280 K
  • 60-Month Beta 0.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.68
Trade AVXL with:

Options Overview Details

View History
  • Implied Volatility 88.18%
  • Historical Volatility 58.93%
  • IV Percentile 4%
  • IV Rank 5.69%
  • IV High 264.87% on 02/04/21
  • IV Low 77.51% on 01/04/21
  • Put/Call Vol Ratio 0.10
  • Today's Volume 2,895
  • Volume Avg (30-Day) 1,444
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 17,604
  • Open Int (30-Day) 16,256

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.14
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.55 +16.23%
on 09/20/21
20.65 -6.88%
on 09/02/21
+0.20 (+1.05%)
since 08/27/21
3-Month
16.55 +16.23%
on 09/20/21
31.50 -38.95%
on 06/28/21
-5.52 (-22.30%)
since 06/25/21
52-Week
3.95 +386.84%
on 10/02/20
31.50 -38.95%
on 06/28/21
+15.36 (+396.90%)
since 09/25/20

Most Recent Stories

More News
Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access 2021

Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...

AVXL : 19.23 (+2.61%)
Anavex Life Sciences Announces Uplisting to the NASDAQ Global Select Market(R)

Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...

AVXL : 19.23 (+2.61%)
Anavex Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference

Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...

AVXL : 19.23 (+2.61%)
Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...

AVXL : 19.23 (+2.61%)
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX(R)2-73 (blarcamesine) in Fragile X Syndrome (Autism)

Published in Scientific Reports, Results Highlight Reversal of Hyperactivity and Restoration of Associative Learning and Reduction of Anxiety, Phenotypes Associated with Fragile X Syndrome

AVXL : 19.23 (+2.61%)
October 1st Options Now Available For Anavex Life Sciences (AVXL)

Investors in Anavex Life Sciences Corp saw new options begin trading today, for the October 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AVXL options chain...

AVXL : 19.23 (+2.61%)
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot

NEW YORK (AP) _ Anavex Life Sciences Corp. (AVXL) on Thursday reported a loss of $10.2 million in its fiscal third quarter.

AVXL : 19.23 (+2.61%)
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Results

-- Exceeding of Enrollment Target for the Precision Medicine ANAVEX2-73 (blarcamesine) Phase 2/3 AVATAR Clinical Trial in Patients with Rett Syndrome

AVXL : 19.23 (+2.61%)
First Week of September 24th Options Trading For Anavex Life Sciences (AVXL)

Investors in Anavex Life Sciences Corp saw new options begin trading this week, for the September 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AVXL options...

AVXL : 19.23 (+2.61%)
Anavex Life Sciences to Announce Fiscal 2021 Third Quarter Financial Results on Thursday, August 12, 2021

Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...

AVXL : 19.23 (+2.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR Discovery Platform involves the rational drug design of compounds that fulfill...

See More

Key Turning Points

3rd Resistance Point 21.16
2nd Resistance Point 20.48
1st Resistance Point 19.86
Last Price 19.23
1st Support Level 18.56
2nd Support Level 17.88
3rd Support Level 17.26

See More

52-Week High 31.50
Fibonacci 61.8% 20.98
Last Price 19.23
Fibonacci 50% 17.73
Fibonacci 38.2% 14.47
52-Week Low 3.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar